-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines Q2 EPS $(3.06) Misses $(1.98) Estimate

Benzinga·08/05/2026 20:06:51
Listen to the news
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(3.06) per share which missed the analyst consensus estimate of $(1.98) by 54.55 percent. This is a 133.59 percent decrease over losses of $(1.31) per share from the same period last year.